Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

Delayed Data
As of Jun 20
 +2.85 / +5.16%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 57.50, with a high estimate of 80.00 and a low estimate of 47.00. The median estimate represents a -0.95% decrease from the last price of 58.05.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.44%
Growthannually 77.91%


Growthquarterly 9.95%
Growthannually 33.16%
Key to the earnings and sales forecast charts.